Table 2. Percentage of corneal opacity scores of the control, bevacizumab (2.5mg) and ranibizumab (1mg) groups.
Groups | Corneal opacity score (%) |
||||
Grade 0 | Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
Saline | 0 | 0 | 20 | 40 | 40 |
Bevacizumab | 0 | 60 | 40 | 0 | 0 |
Ranibizumab | 0 | 40 | 40 | 20 | 0 |